The long-term effects of low-dose 17β-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study

References

• Colditz G A, Willet W C, Stampfer M J, Rosner B, Speizer F E, Hennekens C H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–1110
   PubMed Web of Science ®Google Scholar
• Gordon T. Blood pressure of adults by age and sex: United States 1960–1962. Vital Healthy Stat 1964; 11: 1–40
   Google Scholar
• Grodstein F, Stampfer M J, Manson J E, et al. Postmenopausal estrogen and progestogen use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–461
   PubMed Web of Science ®Google Scholar
• Pines A, Mijatoviç V, van der Mooren M J, Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Reprod Biol 1997; 71: 193–197
   PubMed Web of Science ®Google Scholar
• Mijatoviç V, Kenemans P, Jakops C, van Baal W M, Peters-Muller E R, van der Mooren M J. A randomized controlled study of the effects of 17β-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91: 432–436
   PubMed Web of Science ®Google Scholar
• The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 264: E490–E496
   Google Scholar
• American Society of Hypertension. Recommendation for routine blood pressure measurements by indirect cuff sphygmomanometry. Am J Hypertens 1992; 5: 207–209
   PubMed Web of Science ®Google Scholar
• Cacciatore B, Paakkari I, Hasselblat R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol 2001; 184: 904–909
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199–208
   PubMed Web of Science ®Google Scholar
• van Ittersum F J, van Baal W M, Kenemans P, et al. Ambulatory-not office-blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998; 11: 1147–1152
   PubMed Web of Science ®Google Scholar
• Pripp U M, Hall G, Landgren B M, et al. The influence of long-term HRT treatment on ambulatory blood pressure in older women with coronary artery disease. Presented at 8th International Congress on the Menopause, SydneyAustralia, November, 3–71996, (Abstr F178)
   Google Scholar
• Landahl S, Bengtsson C, Sigurdsson J A, et al. Age-related changes in blood pressure. Hypertension 1986; 8: 1044–1049
   PubMed Web of Science ®Google Scholar
• Harlan W R, Hull A L, Schumouder R L, et al. Blood pressure and nutrition in adults. The National Healty and Nutrition Examination Survey. Am J Epidemiol 1984; 120: 17–28
   PubMed Web of Science ®Google Scholar
• Kannel W B, Hjortland M C, McNamara P M, et al. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447–452
   PubMed Web of Science ®Google Scholar
• Parrish H M, Carr L A, Hall D G. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 1967; 99: 155–162
   PubMed Web of Science ®Google Scholar
• Anastos K, Charney P, Charon R A, et al. Hypertenson in women: what is really known? The Women's Caucus, Working Group on Women of the Society of General Internal Medicine. Ann Intern Med 1991; 115: 287–293
   PubMed Web of Science ®Google Scholar
• Kitler M E. Differences in men and women in coronary artery disease, systemic hypertension and their treatment. Am J Cardiol 1992; 70: 1077–1080
   PubMed Web of Science ®Google Scholar
• Palatini P, Penzo M, Raciooppa A, et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992; 152: 1855–1860
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Muıesan M L, Montani G, et al. Relationship between initial cardiovascular structural changes and daytime and nighttime blooıd pressure monitoring. Am J Hypertens 1992; 5: 180–186
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Gatteschi C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993; 88: 986–992
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillachi G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528–536
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, et al. Gender, day–night blood pressure changes and left ventricular mass in essential hypertension: dippers and peakers. Am J Hypertens 1995; 8: 193–196
   PubMed Web of Science ®Google Scholar
• Schmieder R E, Rockstroh J K, Apfelbacher F, Schulze B, Messerli F H. Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens 1995; 8: 1160–1166
   PubMed Web of Science ®Google Scholar
• Gangar K F, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839–842
   PubMed Web of Science ®Google Scholar
• Nabulsi A A, Folsom A R, White A, et al. for the Atherosclerosis Risk in Communities Study investigators. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069–1075
   PubMed Web of Science ®Google Scholar
• Zhang F, Ram J L, Standley P R, Sowers J R. 17β-estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994; 266: C975–C980
   PubMed Web of Science ®Google Scholar
• Hassager C, Riis B J, Strom V, Guyene T T, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 1987; 76: 753–758
   PubMed Web of Science ®Google Scholar
• Schunkert H, Danser A HJ, Hense H W, Derkx F HM, Kurzinger S, Riegger G AJ. Effects of oestrogen replacement therapy on the renin–angiotensin system in postmenopausal women. Circulation 1997; 95: 39–45
   PubMed Web of Science ®Google Scholar
• Cheng D Y, Gruetter C A. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur J Pharmacol 1992; 215: 171–176
   PubMed Web of Science ®Google Scholar
• Mercuro G, Zoncu S, Pilia I, Lao A, Melis G B, Cherchi A. Effects of acute administration of transdermal estrogen on postmenopaual women with systemic hypertension. Am J Cardiol 1997; 80: 652–655
   PubMed Web of Science ®Google Scholar
• Akkad A A, Halligan A W, Abrams K, et al. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997; 89: 97–103
   PubMed Web of Science ®Google Scholar